RESEDA, CA - March 19, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new educational resource ...
D-serine as an adjunctive treatment did not outperform placebo overall in patients with major depressive disorder (MDD), a new trial showed. However, depressive symptoms and anhedonia were ...
Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...
In 2024, MUSC Health became the first hospital system to offer a revolutionary new depression treatment to patients, taking a successful innovation a leap further. Stanford Neuromodulation Therapy, or ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...
MedPage Today on MSN
Psilocybin failed to live up to hype for treatment-resistant depression
Researchers questioned psychedelic's true efficacy in unblinded trials ...
How do I know if I need therapy or medication (or both)? Living with any mental health condition can feel overwhelming at times. Chances are, if you’re reading this article, you’re probably looking ...
PsyPost on MSN
Genetic risk for major depression linked to lower self-esteem years before severe diagnosis
A recent study published in the journal Molecular Psychiatry provides evidence that an individual’s genetic risk for major depression tends to be higher in those who develop more severe forms of the ...
Additionally, some patients report distressing withdrawal symptoms when they try to stop, such as insomnia, anxiety, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results